Scientists believe they have found an effective target for killing late-stage, metastatic prostate cancer cells. They are focusing on the function of a gene called Polo-like kinase (Plk1), a critical regulator of the cell cycle. Plk1 is also an oncogene, which tends to mutate and can cause cancer.